MiR-142-5p serves as a tumor suppressor in retinoblastoma cells by regulating MYCN
Hongxia Li(North Sichuan Medical University), Yanxia Huang(Shanghai Jiao Tong University), Dongsheng Fan(King University), Wanli Wang(Luoyang Central Hospital Affiliated to Zhengzhou University), Lili Song(Tianjin University of Traditional Chinese Medicine), Xinli Zhang(Anhui Medical University)
Cited by 9
Related Papers
Stroke in China: advances and challenges in epidemiology, prevention, and management
|The Lancet Neurology|2019|1.6k
Estimated Burden of Stroke in China in 2020
|JAMA Network Open|2023|595
China stroke surveillance report 2021
|Military Medical Research|2023|554
Improved precision of epigenetic clock estimates across tissues and its implication for biological ageing
|Genome Medicine|2019|537
Global variation in prevalence and incidence of amyotrophic lateral sclerosis: a systematic review and meta-analysis
|Journal of Neurology|2019|315